YDES
YD Bio Limited Ordinary Shares (YDES) SWOT Analysis Analysis (2026)
Strengths
Current liquidity is strong versus peers, with a 5.9x current ratio and 4.7x quick ratio, which supports near-term obligations better than most leveraged comparables.
Net debt to EBITDA is only 1.1x, indicating moderate balance-sheet pressure and leaving more financial flexibility than higher-leverage peers.
Cash conversion cycle is reported at zero, suggesting working-capital efficiency that can help preserve liquidity relative to peers with longer cash cycles.
Weaknesses
ROIC is -6.1%, showing the business is destroying value and lagging peers that generate positive returns on invested capital.
The absence of reported operating and gross margins limits evidence of earnings quality, while peers with clearer margin profiles appear structurally stronger.
Debt-to-equity is effectively neutral, but the negative ROIC implies capital is not being deployed productively, weakening competitive positioning versus profitable peers.
Opportunities
If management converts strong liquidity into higher-return deployment, YDES could narrow the gap with peers that already compound capital more efficiently.
Low leverage relative to many peers creates room to fund operational improvements without immediate balance-sheet strain, supporting longer-term positioning.
Working-capital efficiency can be leveraged to improve reinvestment capacity, which would matter most if peers remain more cash-intensive.
Threats
Persistent negative ROIC threatens long-term competitiveness because peers with positive capital returns can reinvest faster and widen structural gaps.
If liquidity is used to offset weak profitability rather than growth, YDES may remain behind peers that convert balance-sheet strength into earnings power.
Limited margin disclosure increases uncertainty, and peers with transparent, durable margins are better positioned to sustain pricing and investor confidence.
Overall Score
YDES shows balance-sheet resilience but weak capital efficiency, leaving it structurally behind peers that generate positive returns and durable operating profitability.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on YD Bio Limited Ordinary Shares. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

